Menoxenia vigilance polycystic ovary syndrome

Xiaoli, a senior high school students to irregular menstrual always at home near the hospital saw many doctors never diagnosed. Not long ago, she came to Beijing for medical treatment, after careful examination, the doctor told her mother, Xiaoli is suffering from polycystic ovary syndrome. Name one of the many patients and their families face loss. In fact, with medical checks means continuous improvement, the doctors discovered that patients with polycystic ovarian syndrome in women of childbearing age is very common, accounted for 6% -10%, has been considerable, but the public know little about the disease. From the incidence of endocrine disorders and Xiaoli's mother, Many people do not know that women with polycystic ovary syndrome in the end is how the case. Polycystic ovary syndrome (PCOS) is an endocrine and metabolic disorder, characterized by a two, First, ovulation disorders or loss of two patients with androgen excess. Study found that patients with secondary amenorrhea 30% of women with polycystic ovary syndrome, and 75% of non-ovulatory infertility stems from the disease. This shows that young women with polycystic ovary syndrome, the greatest hazard of infertility. Recent studies have shown that women with polycystic ovary syndrome and type 2 diabetes, dyslipidemia and cardiovascular diseases metabolic disorders, there exists the long-term complications. In recent years much attention to the medical profession. Adolescent onset of polycystic ovary syndrome began more after the onset of menstruation. Many adolescent girls menstruating irregular menstruation, but generally limited to two years after menarche. If more than two years after abnormal still, we must guard against the possibility of polycystic ovary syndrome. In addition to menstrual disorders, polycystic ovary syndrome and the clinical manifestation of the very endocrine characteristics, For experienced doctors, the diagnosis is not difficult. From the exterior speaking, these patients are often obese, and the performance of abdominal obesity, in addition, the majority of patients felt more hair, Some have acne vulgaris, seborrheic dermatitis, and so on. Checks can be found, these patients without ovulation, which lead to infertility; B-so patients can be seen on a number of ovarian follicles. Currently, the incidence of polycystic ovary syndrome reasons still unclear, people speculate it may be more than a genetic disease. Such patients have a certain familial aggregation, many patients have the father of hair, acne vulgaris, seborrheic dermatitis, as early as bald, his mother and sister were many Oligomenorrnea, infertility. First slimming treatment to the treatment of polycystic ovary syndrome, we must first change their lifestyle to adjust your diet, weight control. Studies indicate that body mass index (BMI) decreased to improve the situation of patients with ovulation, promote fertility. Moreover, people have found that the weight can reduce insulin and patients with androgen levels return to normal menstruation and ovulation. Specifically the reduction of abdominal fat, can reduce patients with insulin resistance. In general, 5% weight loss can reduce hirsutism, acne and other symptoms hormone Kaohsiung. Therefore, in patients with polycystic ovary syndrome, the choice of sugar, and low-fat diet and exercise to strengthen and reduce weight is cheap. effective method. In addition, oral contraceptives has now become the polycystic ovary syndrome may be long-term use of drugs, mainly used to protect the endometrium, adjust the menstrual cycle, and through the lower ovarian androgen improvement of acne and hair symptoms. Combined with obesity, insulin resistance in patients taking metformin treatment can be. Despite the application of metformin dose, timing and the issue is being further study, but most of the studies that metformin for PCOS patients are safe. Infertility due to the need to promote ovulation in patients with polycystic ovarian syndrome may lead to infertility, reproductive requirements of the patients, the need for ovulation induction treatment. The good news is that in the last 50 years, women with polycystic ovary syndrome ovulation induction drugs has made great progress. Currently clomiphene citrate ovulation induction therapy is the preferred drug. If the use of clomiphene citrate invalid and can be applied gonadotropin, But to the attention of multiple pregnancy and ovarian hyperstimulation syndrome risk. However, whether patients with natural pregnancy or through drug ovulation pregnancy, the baby born with no difference between the normal, parents need not be concerned. Need to remind the majority of patients noted that women with polycystic ovary syndrome is endometrial hyperplasia, or even the risk of cancer. Therefore, long-term amenorrhea patients should accept the endometrial biopsy to eliminate hidden dangers.